
The pace at which the vaccinations are happening in India is so slow that it cannot save the nation from the upcoming third wave, as per some experts in the field.

Former Congress chief Rahul Gandhi on Tuesday released the party's 'White Paper' on management of Covid-19, accusing the Central government of not taking adequate measures to prevent and contain the pandemic.

As studies conducted by the Tamil Nadu State Public Health revealed that the Delta Covid variant has led to a majority of positive cases in the state, experts are of the opinion that children and teenagers should be inoculated against the virus at the earliest after conducting trials.

The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run.

STAR continued to remain the undoubted leader among broadcasters in May, with group level viewership share of 39.4 per cent, slightly down on high base of IPL viewership in April'21, according to a research by Elara Securities.

Online ticketing platform BookMyShow has laid off 200 employees as the Covid-19 pandemic continues to affect businesses.

The Indian government's Covid-19 vaccination approach has inappropriately prioritised people and is thus causing huge numbers of avertable deaths, warn a team of nine experts from research institutes in the UK and India.

US pharmaceutical major Pfizer may price its mRNA-based Covid-19 vaccine, co-developed by BioNTech, below $10 (about Rs 730) a dose in India, sources close to the development indicated.

India's daily Covid-19 cases remained below the 100,000 again today, however, the daily death record saw a massive spike.

Entire world is in the vaccination drive to combat Covid-19. Different countries are inoculating their people with respective vaccines.

India on Monday recorded less than 1 lakh new cases after 68 days while the toll reached below 2,000 after 49 days.

As the second wave of coronavirus has been indicating a declining trend in India for the last few days, Prime Minister Narendra Modi on Monday announced that all Indians above 18 years of age will be administered free Covid-19 vaccine from June 21.

A study conducted by Coronavirus Vaccine-induced Antibody Titre (COVAT) has found that seropositivity rates and median anti-spike antibody titre was significantly higher in Astra Zeneca’s Covishield as compared to Bharat Biotech’s Covaxin.

In an incident that shows that Twitter can withdraw the blue verified badge against any verified account irrespective of the importance of the position of the account holder, the social media

Even amidst fears there are myths surrounding the vaccination. Some are still believing that even the the people who got the two jabs of vaccine are not completely shielded by the virus.